Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing

Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing

MT newswireMT newswire2026/09/28 11:14
07:14 AM EDT, 09/28/2026 (MT Newswires) -- Jennifer Jarrett, Director, Director, President and Chief Executive Officer, on September 25, 2026, executed a purchase for 12,500 shares in Damora Therapeutics (DMRA) for $252,875. Following the Form 4 filing with the SEC, Jarrett has control over a total of 512,500 ordinary shares of the company, with 512,500 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800315/000119312526403355/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries

Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.

智通财经•2026/11/10 02:32
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries